{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T23:24:11Z","timestamp":1789687451794,"version":"4.0.1"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T00:00:00Z","timestamp":1759708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T00:00:00Z","timestamp":1759708800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Managing multiple sclerosis (MS), a chronic, neuroinflammatory and demyelinating disease, remains an unmet medical need. A great obstacle to developing therapeutic interventions altering the disease process is the lack of a suitable disease model recapitulating its core pathologies, especially the process of myelin damage and regeneration against the backdrop of persistent neuroinflammation. Now we report the generation and characterization of a new demyelination\/remyelination model with key pathological features of MS through repeated ablations of Tmem10<jats:sup>+<\/jats:sup> oligodendrocytes. Using the Tmem10-Cre driver that targets expression of diphtheria toxin receptor (DTR) in Tmem10<jats:sup>+<\/jats:sup> (mature myelin-forming) oligodendrocytes, we conducted 3 rounds of Tmem10<jats:sup>+<\/jats:sup> oligodendrocyte ablations over the span of 9 weeks in young adult mice by injecting diphtheria toxin (DT). Three rounds of the oligodendrocyte ablation caused prolonged demyelination and axonal injury in the backdrop of chronic neuroinflammation, including gliosis and lymphocyte infiltration. In response to the oligodendrocyte ablations, the proliferation and differentiation of OPCs were accelerated for the regeneration of myelin-forming oligodendrocytes, leading to spontaneous remyelination. This de-\/re-myelination model presents a wide \u201ctime window\u201d between the onset of demyelination and spontaneous remyelination, which makes it suitable for assessing the efficacy of therapeutic pro-remyelinating agents, as demonstrated by administering Benztropine to this demyelination model.<\/jats:p>","DOI":"10.1038\/s41419-025-07996-0","type":"journal-article","created":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T14:04:40Z","timestamp":1759759480000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Repeated ablations of mature Tmem10+ oligodendrocytes recapitulates key pathological features of multiple sclerosis with prolonged demyelination"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3790-2679","authenticated-orcid":false,"given":"Feiyan","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haijiao","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuting","family":"Shu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoru","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Jing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Honglin","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanxiang","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiyuan","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul F.","family":"Worley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6161-9478","authenticated-orcid":false,"given":"Bo","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7446-3978","authenticated-orcid":false,"given":"Mina","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,6]]},"reference":[{"key":"7996_CR1","doi-asserted-by":"crossref","unstructured":"Lassmann H. Multiple sclerosis pathology. Cold Spring Harbor Perspect Med. 2018;8.","DOI":"10.1101\/cshperspect.a028936"},{"key":"7996_CR2","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1056\/NEJMra1401483","volume":"378","author":"DS Reich","year":"2018","unstructured":"Reich DS, Lucchinetti CF, Calabresi PA. Multiple sclerosis. New Engl J Med. 2018;378:169\u201380.","journal-title":"New Engl J Med"},{"key":"7996_CR3","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/ene.13819","volume":"26","author":"R Dobson","year":"2019","unstructured":"Dobson R, Giovannoni G. Multiple sclerosis\u2014a review. European J Neurol. 2019;26:27\u201340.","journal-title":"European J Neurol"},{"key":"7996_CR4","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1177\/1352458519858604","volume":"26","author":"BV Ineichen","year":"2020","unstructured":"Ineichen BV, Moridi T, Granberg T, Piehl F. Rituximab treatment for multiple sclerosis. Multiple Scler (Houndmills, Basingstoke, Engl). 2020;26:137\u201352.","journal-title":"Multiple Scler (Houndmills, Basingstoke, Engl)"},{"key":"7996_CR5","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1038\/nrneurol.2012.168","volume":"8","author":"H Lassmann","year":"2012","unstructured":"Lassmann H, van Horssen J, Mahad D. Progressive multiple sclerosis: pathology and pathogenesis. Nature Rev Neurol. 2012;8:647\u201356.","journal-title":"Nature Rev Neurol"},{"key":"7996_CR6","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1212\/WNL.0000000000012323","volume":"97","author":"BAC Cree","year":"2021","unstructured":"Cree BAC, Arnold DL, Chataway J, Chitnis T, Fox RJ, Pozo Ramajo A, et al. Secondary progressive multiple sclerosis: new insights. Neurology. 2021;97:378\u201388.","journal-title":"Neurology"},{"key":"7996_CR7","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/nrn2480","volume":"9","author":"RJ Franklin","year":"2008","unstructured":"Franklin RJ, Ffrench-Constant C. Remyelination in the CNS: from biology to therapy. Nat Rev Neurosci. 2008;9:839\u201355.","journal-title":"Nat Rev Neurosci"},{"key":"7996_CR8","first-page":"527","volume":"140","author":"J Correale","year":"2017","unstructured":"Correale J, Gait\u00e1n MI, Ysrraelit MC, Fiol MP. Progressive multiple sclerosis: from pathogenic mechanisms to treatment. Brain: J Neurol. 2017;140:527\u201346.","journal-title":"Brain: J Neurol"},{"key":"7996_CR9","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1093\/brain\/awn080","volume":"131","author":"KA Irvine","year":"2008","unstructured":"Irvine KA, Blakemore WF. Remyelination protects axons from demyelination-associated axon degeneration. Brain: J Neurol. 2008;131:1464\u201377.","journal-title":"Brain: J Neurol"},{"key":"7996_CR10","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1111\/ene.15285","volume":"29","author":"VAG Ricigliano","year":"2022","unstructured":"Ricigliano VAG, Tonietto M, Hamzaoui M, Poirion \u00c9, Lazzarotto A, Bottlaender M, et al. Spontaneous remyelination in lesions protects the integrity of surrounding tissues over time in multiple sclerosis. Eur J Neurol. 2022;29:1719\u201329.","journal-title":"Eur J Neurol"},{"key":"7996_CR11","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1093\/brain\/awn096","volume":"131","author":"T Kuhlmann","year":"2008","unstructured":"Kuhlmann T, Miron V, Cui Q, Wegner C, Antel J, Br\u00fcck W. Differentiation block of oligodendroglial progenitor cells as a cause for remyelination failure in chronic multiple sclerosis. Brain: J Neurol. 2008;131:1749\u201358.","journal-title":"Brain: J Neurol"},{"key":"7996_CR12","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1056\/NEJMoa010994","volume":"346","author":"A Chang","year":"2002","unstructured":"Chang A, Tourtellotte WW, Rudick R, Trapp BD. Premyelinating oligodendrocytes in chronic lesions of multiple sclerosis. New Engl J Med. 2002;346:165\u201373.","journal-title":"New Engl J Med"},{"key":"7996_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2022.995477","volume":"15","author":"M Gharagozloo","year":"2022","unstructured":"Gharagozloo M, Mace JW, Calabresi PA. Animal models to investigate the effects of inflammation on remyelination in multiple sclerosis. Front Mol Neurosci. 2022;15:995477.","journal-title":"Front Mol Neurosci"},{"key":"7996_CR14","doi-asserted-by":"publisher","first-page":"4349","DOI":"10.4049\/jimmunol.153.10.4349","volume":"153","author":"S Amor","year":"1994","unstructured":"Amor S, Groome N, Linington C, Morris MM, Dornmair K, Gardinier MV, et al. Identification of epitopes of myelin oligodendrocyte glycoprotein for the induction of experimental allergic encephalomyelitis in SJL and Biozzi AB\/H mice. J Immunol. 1994;153:4349\u201356.","journal-title":"J Immunol"},{"key":"7996_CR15","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1038\/nn.3168","volume":"15","author":"RM Ransohoff","year":"2012","unstructured":"Ransohoff RM. Animal models of multiple sclerosis: the good, the bad and the bottom line. Nature Neurosci. 2012;15:1074\u20137.","journal-title":"Nature Neurosci"},{"key":"7996_CR16","doi-asserted-by":"publisher","first-page":"14128","DOI":"10.1523\/JNEUROSCI.3491-13.2014","volume":"34","author":"YL Xing","year":"2014","unstructured":"Xing YL, R\u00f6th PT, Stratton JA, Chuang BH, Danne J, Ellis SL, et al. Adult neural precursor cells from the subventricular zone contribute significantly to oligodendrocyte regeneration and remyelination. J Neurosci. 2014;34:14128\u201346.","journal-title":"J Neurosci"},{"key":"7996_CR17","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1002\/glia.20688","volume":"56","author":"N Golan","year":"2008","unstructured":"Golan N, Adamsky K, Kartvelishvily E, Brockschnieder D, M\u00f6bius W, Spiegel I, et al. Identification of Tmem10\/Opalin as an oligodendrocyte enriched gene using expression profiling combined with genetic cell ablation. Glia. 2008;56:1176\u201386.","journal-title":"Glia"},{"key":"7996_CR18","doi-asserted-by":"publisher","first-page":"33","DOI":"10.7150\/ijbs.7526","volume":"10","author":"W Jiang","year":"2013","unstructured":"Jiang W, Yang W, Yang W, Zhang J, Pang D, Gan L, et al. Identification of Tmem10 as a novel late-stage oligodendrocytes marker for detecting hypomyelination. Int J Biol Sci. 2013;10:33\u201342.","journal-title":"Int J Biol Sci"},{"key":"7996_CR19","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/s41586-019-0903-2","volume":"566","author":"S J\u00e4kel","year":"2019","unstructured":"J\u00e4kel S, Agirre E, Mendanha Falc\u00e3o A, van Bruggen D, Lee KW, Knuesel I, et al. Altered human oligodendrocyte heterogeneity in multiple sclerosis. Nature. 2019;566:543\u20137.","journal-title":"Nature"},{"key":"7996_CR20","doi-asserted-by":"publisher","first-page":"e0166732","DOI":"10.1371\/journal.pone.0166732","volume":"11","author":"F Yoshikawa","year":"2016","unstructured":"Yoshikawa F, Sato Y, Tohyama K, Akagi T, Furuse T, Sadakata T, et al. Mammalian-specific central myelin protein opalin is redundant for normal myelination: structural and behavioral assessments. PloS one. 2016;11:e0166732.","journal-title":"PloS one"},{"key":"7996_CR21","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1038\/nmeth762","volume":"2","author":"T Buch","year":"2005","unstructured":"Buch T, Heppner FL, Tertilt C, Heinen TJ, Kremer M, Wunderlich FT, et al. A Cre-inducible diphtheria toxin receptor mediates cell lineage ablation after toxin administration. Nature Methods. 2005;2:419\u201326.","journal-title":"Nature Methods"},{"key":"7996_CR22","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1002\/ana.410330203","volume":"33","author":"JW Prineas","year":"1993","unstructured":"Prineas JW, Barnard RO, Kwon EE, Sharer LR, Cho ES. Multiple sclerosis: remyelination of nascent lesions. Annals Neurol. 1993;33:137\u201351.","journal-title":"Annals Neurol"},{"key":"7996_CR23","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1523\/JNEUROSCI.18-01-00237.1998","volume":"18","author":"K Kuhlbrodt","year":"1998","unstructured":"Kuhlbrodt K, Herbarth B, Sock E, Hermans-Borgmeyer I, Wegner M. Sox10, a novel transcriptional modulator in glial cells. J Neurosci. 1998;18:237\u201350.","journal-title":"J Neurosci"},{"key":"7996_CR24","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.cell.2009.04.031","volume":"138","author":"B Emery","year":"2009","unstructured":"Emery B, Agalliu D, Cahoy JD, Watkins TA, Dugas JC, Mulinyawe SB, et al. Myelin gene regulatory factor is a critical transcriptional regulator required for CNS myelination. Cell. 2009;138:172\u201385.","journal-title":"Cell"},{"key":"7996_CR25","doi-asserted-by":"publisher","first-page":"12528","DOI":"10.1523\/JNEUROSCI.1069-12.2012","volume":"32","author":"M Koenning","year":"2012","unstructured":"Koenning M, Jackson S, Hay CM, Faux C, Kilpatrick TJ, Willingham M, et al. Myelin gene regulatory factor is required for maintenance of myelin and mature oligodendrocyte identity in the adult CNS. Journal Neurosci. 2012;32:12528\u201342.","journal-title":"Journal Neurosci"},{"key":"7996_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0169-328X(98)00040-0","volume":"57","author":"D Ito","year":"1998","unstructured":"Ito D, Imai Y, Ohsawa K, Nakajima K, Fukuuchi Y, Kohsaka S. Microglia-specific localisation of a novel calcium binding protein, Iba1. Brain Res Mol Brain Res. 1998;57:1\u20139.","journal-title":"Brain Res Mol Brain Res"},{"key":"7996_CR27","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.1073\/pnas.252784899","volume":"100","author":"K Ohmi","year":"2003","unstructured":"Ohmi K, Greenberg DS, Rajavel KS, Ryazantsev S, Li HH, Neufeld EF. Activated microglia in cortex of mouse models of mucopolysaccharidoses I and IIIB. Proc. Natl Acad Sci USA. 2003;100:1902\u20137.","journal-title":"Proc. Natl Acad Sci USA"},{"key":"7996_CR28","doi-asserted-by":"publisher","first-page":"14833","DOI":"10.1073\/pnas.93.25.14833","volume":"93","author":"MP Ramprasad","year":"1996","unstructured":"Ramprasad MP, Terpstra V, Kondratenko N, Quehenberger O, Steinberg D. Cell surface expression of mouse macrosialin and human CD68 and their role as macrophage receptors for oxidized low density lipoprotein. Proc Natl Acad Sci USA. 1996;93:14833\u20138.","journal-title":"Proc Natl Acad Sci USA"},{"key":"7996_CR29","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.ceb.2015.02.004","volume":"32","author":"EM Hol","year":"2015","unstructured":"Hol EM, Pekny M. Glial fibrillary acidic protein (GFAP) and the astrocyte intermediate filament system in diseases of the central nervous system. Curr Opin Cell Biol. 2015;32:121\u201330.","journal-title":"Curr Opin Cell Biol"},{"key":"7996_CR30","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1093\/brain\/awaa117","volume":"143","author":"NL Fransen","year":"2020","unstructured":"Fransen NL, Hsiao CC, van der Poel M, Engelenburg HJ, Verdaasdonk K, Vincenten MCJ, et al. Tissue-resident memory T cells invade the brain parenchyma in multiple sclerosis white matter lesions. Brain. 2020;143:1714\u201330.","journal-title":"Brain"},{"key":"7996_CR31","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/j.bbi.2010.01.014","volume":"24","author":"AC Murphy","year":"2010","unstructured":"Murphy AC, Lalor SJ, Lynch MA, Mills KH. Infiltration of Th1 and Th17 cells and activation of microglia in the CNS during the course of experimental autoimmune encephalomyelitis. Brain Behav Immun. 2010;24:641\u201351.","journal-title":"Brain Behav Immun"},{"key":"7996_CR32","doi-asserted-by":"publisher","first-page":"2066","DOI":"10.1093\/brain\/awy151","volume":"141","author":"J Machado-Santos","year":"2018","unstructured":"Machado-Santos J, Saji E, Tr\u00f6scher AR, Paunovic M, Liblau R, Gabriely G, et al. The compartmentalized inflammatory response in the multiple sclerosis brain is composed of tissue-resident CD8+ T lymphocytes and B cells. Brain. 2018;141:2066\u201382.","journal-title":"Brain"},{"key":"7996_CR33","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1007\/s00401-017-1744-4","volume":"134","author":"GP van Nierop","year":"2017","unstructured":"van Nierop GP, van Luijn MM, Michels SS, Melief MJ, Janssen M, Langerak AW, et al. Phenotypic and functional characterization of T cells in white matter lesions of multiple sclerosis patients. Acta Neuropathol. 2017;134:383\u2013401.","journal-title":"Acta Neuropathol"},{"key":"7996_CR34","doi-asserted-by":"publisher","first-page":"3017","DOI":"10.1093\/brain\/awq247","volume":"133","author":"M Traka","year":"2010","unstructured":"Traka M, Arasi K, Avila RL, Podojil JR, Christakos A, Miller SD, et al. A genetic mouse model of adult-onset, pervasive central nervous system demyelination with robust remyelination. Brain. 2010;133:3017\u201329.","journal-title":"Brain"},{"key":"7996_CR35","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1523\/JNEUROSCI.5035-10.2011","volume":"31","author":"HB Pohl","year":"2011","unstructured":"Pohl HB, Porcheri C, Mueggler T, Bachmann LC, Martino G, Riethmacher D, et al. Genetically induced adult oligodendrocyte cell death is associated with poor myelin clearance, reduced remyelination, and axonal damage. J Neurosci. 2011;31:1069\u201380.","journal-title":"J Neurosci"},{"key":"7996_CR36","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/B978-0-444-52001-2.00005-4","volume":"122","author":"G Criste","year":"2014","unstructured":"Criste G, Trapp B, Dutta R. Axonal loss in multiple sclerosis: causes and mechanisms. Handbook Clin Neurol. 2014;122:101\u201313.","journal-title":"Handbook Clin Neurol"},{"key":"7996_CR37","doi-asserted-by":"publisher","first-page":"2202","DOI":"10.1093\/brain\/awf235","volume":"125","author":"T Kuhlmann","year":"2002","unstructured":"Kuhlmann T, Lingfeld G, Bitsch A, Schuchardt J, Br\u00fcck W. Acute axonal damage in multiple sclerosis is most extensive in early disease stages and decreases over time. Brain. 2002;125:2202\u201312.","journal-title":"Brain"},{"key":"7996_CR38","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1177\/107385849900500107","volume":"5","author":"BD Trapp","year":"1999","unstructured":"Trapp BD, Ransohoff RM, Fisher E, Rudick RA. Neurodegeneration in multiple sclerosis: relationship to neurological disability. Neuroscientist. 1999;5:48\u201357.","journal-title":"Neuroscientist"},{"key":"7996_CR39","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/nrneurol.2014.37","volume":"10","author":"MA Friese","year":"2014","unstructured":"Friese MA, Schattling B, Fugger L. Mechanisms of neurodegeneration and axonal dysfunction in multiple sclerosis. Nat Rev Neurol. 2014;10:225\u201338.","journal-title":"Nat Rev Neurol"},{"key":"7996_CR40","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1056\/NEJM199801293380502","volume":"338","author":"BD Trapp","year":"1998","unstructured":"Trapp BD, Peterson J, Ransohoff RM, Rudick R, M\u00f6rk S, B\u00f6 L. Axonal transection in the lesions of multiple sclerosis. New Engl J Med. 1998;338:278\u201385.","journal-title":"New Engl J Med"},{"key":"7996_CR41","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1038\/nrn917","volume":"3","author":"RJ Franklin","year":"2002","unstructured":"Franklin RJ. Why does remyelination fail in multiple sclerosis?. Nature Rev Neurosci. 2002;3:705\u201314.","journal-title":"Nature Rev Neurosci"},{"key":"7996_CR42","doi-asserted-by":"crossref","unstructured":"Fard MK, van der Meer F, S\u00e1nchez P, Cantuti-Castelvetri L, Mandad S, J\u00e4kel S, et al. BCAS1 expression defines a population of early myelinating oligodendrocytes in multiple sclerosis lesions. Sci Transl Med. 2017;9.","DOI":"10.1126\/scitranslmed.aam7816"},{"key":"7996_CR43","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/nature12647","volume":"502","author":"VA Deshmukh","year":"2013","unstructured":"Deshmukh VA, Tardif V, Lyssiotis CA, Green CC, Kerman B, Kim HJ, et al. A regenerative approach to the treatment of multiple sclerosis. Nature. 2013;502:327\u201332.","journal-title":"Nature"},{"key":"7996_CR44","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1038\/nrneurol.2013.225","volume":"9","author":"E Bible","year":"2013","unstructured":"Bible E. Multiple sclerosis: Drug-enhanced remyelination in a multiple sclerosis model. Nat Rev Neurol. 2013;9:660.","journal-title":"Nat Rev Neurol"},{"key":"7996_CR45","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1038\/nature12694","volume":"502","author":"H Wekerle","year":"2013","unstructured":"Wekerle H, Meinl E. Multiple sclerosis: An old drug plays a new trick. Nature. 2013;502:314\u20135.","journal-title":"Nature"},{"key":"7996_CR46","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1038\/nm.3618","volume":"20","author":"F Mei","year":"2014","unstructured":"Mei F, Fancy SPJ, Shen YA, Niu J, Zhao C, Presley B, et al. Micropillar arrays as a high-throughput screening platform for therapeutics in multiple sclerosis. Nat Med. 2014;20:954\u201360.","journal-title":"Nat Med"},{"key":"7996_CR47","doi-asserted-by":"publisher","first-page":"8317","DOI":"10.1523\/JNEUROSCI.1053-12.2012","volume":"32","author":"LJ Oluich","year":"2012","unstructured":"Oluich LJ, Stratton JA, Xing YL, Ng SW, Cate HS, Sah P, et al. Targeted ablation of oligodendrocytes induces axonal pathology independent of overt demyelination. J Neurosci. 2012;32:8317\u201330.","journal-title":"J Neurosci"},{"key":"7996_CR48","doi-asserted-by":"publisher","first-page":"e22735","DOI":"10.1371\/journal.pone.0022735","volume":"6","author":"A Ghosh","year":"2011","unstructured":"Ghosh A, Manrique-Hoyos N, Voigt A, Schulz JB, Kreutzfeldt M, Merkler D, et al. Targeted ablation of oligodendrocytes triggers axonal damage. PLoS ONE. 2011;6:e22735.","journal-title":"PLoS ONE"},{"key":"7996_CR49","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/nn.4193","volume":"19","author":"M Traka","year":"2016","unstructured":"Traka M, Podojil JR, McCarthy DP, Miller SD, Popko B. Oligodendrocyte death results in immune-mediated CNS demyelination. Nat Neurosci. 2016;19:65\u201374.","journal-title":"Nat Neurosci"},{"key":"7996_CR50","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1038\/s41419-020-03084-7","volume":"11","author":"N Hagan","year":"2020","unstructured":"Hagan N, Kane JL, Grover D, Woodworth L, Madore C, Saleh J, et al. CSF1R signaling is a regulator of pathogenesis in progressive MS. Cell Death Dis. 2020;11:904.","journal-title":"Cell Death Dis"},{"key":"7996_CR51","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1002\/glia.23980","volume":"69","author":"DE Marzan","year":"2021","unstructured":"Marzan DE, Br\u00fcgger-Verdon V, West BL, Liddelow S, Samanta J, Salzer JL. Activated microglia drive demyelination via CSF1R signaling. Glia. 2021;69:1583\u2013604.","journal-title":"Glia"},{"key":"7996_CR52","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1038\/nn.3469","volume":"16","author":"VE Miron","year":"2013","unstructured":"Miron VE, Boyd A, Zhao JW, Yuen TJ, Ruckh JM, Shadrach JL, et al. M2 microglia and macrophages drive oligodendrocyte differentiation during CNS remyelination. Nat Neurosci. 2013;16:1211\u20138.","journal-title":"Nat Neurosci"},{"key":"7996_CR53","doi-asserted-by":"publisher","first-page":"2028","DOI":"10.1016\/j.ajpath.2011.06.006","volume":"179","author":"H Hvilsted Nielsen","year":"2011","unstructured":"Hvilsted Nielsen H, Toft-Hansen H, Lambertsen KL, Owens T, Finsen B. Stimulation of adult oligodendrogenesis by myelin-specific T cells. Am J Pathol. 2011;179:2028\u201341.","journal-title":"Am J Pathol"},{"key":"7996_CR54","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1038\/nn738","volume":"4","author":"HA Arnett","year":"2001","unstructured":"Arnett HA, Mason J, Marino M, Suzuki K, Matsushima GK, Ting JP. TNF alpha promotes proliferation of oligodendrocyte progenitors and remyelination. Nat Neurosci. 2001;4:1116\u201322.","journal-title":"Nat Neurosci"},{"key":"7996_CR55","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/nn.3062","volume":"15","author":"G Locatelli","year":"2012","unstructured":"Locatelli G, W\u00f6rtge S, Buch T, Ingold B, Frommer F, Sobottka B, et al. Primary oligodendrocyte death does not elicit anti-CNS immunity. Nat Neurosci. 2012;15:543\u201350.","journal-title":"Nat Neurosci"},{"key":"7996_CR56","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1038\/s41582-019-0184-2","volume":"15","author":"AF Lloyd","year":"2019","unstructured":"Lloyd AF, Miron VE. The pro-remyelination properties of microglia in the central nervous system. Nat Rev Neurol. 2019;15:447\u201358.","journal-title":"Nat Rev Neurol"},{"key":"7996_CR57","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1002\/glia.21266","volume":"60","author":"M Olah","year":"2012","unstructured":"Olah M, Amor S, Brouwer N, Vinet J, Eggen B, Biber K, et al. Identification of a microglia phenotype supportive of remyelination. Glia. 2012;60:306\u201321.","journal-title":"Glia"},{"key":"7996_CR58","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1002\/ana.10578","volume":"53","author":"AJ Bieber","year":"2003","unstructured":"Bieber AJ, Kerr S, Rodriguez M. Efficient central nervous system remyelination requires T cells. Ann Neurol. 2003;53:680\u20134.","journal-title":"Ann Neurol"},{"key":"7996_CR59","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1093\/brain\/awf031","volume":"125","author":"G Wolswijk","year":"2002","unstructured":"Wolswijk G. Oligodendrocyte precursor cells in the demyelinated multiple sclerosis spinal cord. Brain. 2002;125:338\u201349.","journal-title":"Brain"},{"key":"7996_CR60","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1007\/s00401-013-1112-y","volume":"125","author":"A Boyd","year":"2013","unstructured":"Boyd A, Zhang H, Williams A. Insufficient OPC migration into demyelinated lesions is a cause of poor remyelination in MS and mouse models. Acta Neuropathol. 2013;125:841\u201359.","journal-title":"Acta Neuropathol"},{"key":"7996_CR61","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1093\/brain\/116.3.681","volume":"116","author":"JW Prineas","year":"1993","unstructured":"Prineas JW, Barnard RO, Revesz T, Kwon EE, Sharer L, Cho ES. Multiple sclerosis. Pathology of recurrent lesions. Brain. 1993;116:681\u201393.","journal-title":"Brain"},{"key":"7996_CR62","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1093\/brain\/awg126","volume":"126","author":"J Penderis","year":"2003","unstructured":"Penderis J, Shields SA, Franklin RJ. Impaired remyelination and depletion of oligodendrocyte progenitors does not occur following repeated episodes of focal demyelination in the rat central nervous system. Brain. 2003;126:1382\u201391.","journal-title":"Brain"},{"key":"7996_CR63","doi-asserted-by":"publisher","first-page":"E9685","DOI":"10.1073\/pnas.1714183114","volume":"114","author":"ID Duncan","year":"2017","unstructured":"Duncan ID, Marik RL, Broman AT, Heidari M. Thin myelin sheaths as the hallmark of remyelination persist over time and preserve axon function. Proc Natl Acad Sci USA. 2017;114:E9685\u201391.","journal-title":"Proc Natl Acad Sci USA"},{"key":"7996_CR64","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.devcel.2010.11.020","volume":"20","author":"J Zou","year":"2011","unstructured":"Zou J, Zhou L, Du XX, Ji Y, Xu J, Tian J, et al. Rheb1 is required for mTORC1 and myelination in postnatal brain development. Dev Cell. 2011;20:97\u2013108.","journal-title":"Dev Cell"},{"key":"7996_CR65","doi-asserted-by":"crossref","unstructured":"Yu Z, Yang Z, Ren G, Wang Y, Luo X, Zhu F, et al. GATOR2 complex-mediated amino acid signaling regulates brain myelination. Proc Natl Acad Sci USA 2022;119.","DOI":"10.1073\/pnas.2110917119"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07996-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07996-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07996-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T15:21:25Z","timestamp":1759764085000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07996-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,6]]},"references-count":65,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["7996"],"URL":"https:\/\/doi.org\/10.1038\/s41419-025-07996-0","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,6]]},"assertion":[{"value":"18 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"691"}}